Enter assignee name

Forward Citations = 18

Loading Chart...

14 inventors (with patents filed for the assignee):

Luke Evnin (4 out of 23 patents)

Jeanmarie Guenot (4 out of 16 patents)

Lori Kunkel (4 out of 7 patents)

4. Kristina Ellwanger (3 out of 11 patents)

5. Michael Weichel (3 out of 7 patents)

6. Uwe Reusch (3 out of 19 patents)

7. Stefan Knackmuss (3 out of 15 patents)

8. Judith A Fox (3 out of 7 patents)

9. Ivica Fucek (3 out of 11 patents)

10. Vera Molkenthin (3 out of 5 patents)

11. Erich Rajkovic (3 out of 10 patents)

12. Claudia Wall (3 out of 3 patents)

13. Eugene Zhukovsky (3 out of 5 patents)

14. Melvyn Little (3 out of 23 patents)

4 patents: Sort by Forward Citations

1. 10738118 - Methods of using bispecific CD33 and CD3 binding proteins (2020-08-11),

2. 10626190 - Bispecific CD33 and CD3 binding proteins (2020-04-21),

3. 9803029 - Bispecific CD33 and CD3 binding proteins (2017-10-31),

4. 9212225 - Bispecific CD33 and CD3 binding proteins (2015-12-15),

Amphivena Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative immunotherapies for the treatment of cancer. The company is dedicated to advancing novel therapies that harness the power of the immune system to target and eliminate cancer cells. Amphivena's pipeline includes promising candidates designed to enhance the body's natural immune response to cancer, offering new hope to patients facing difficult-to-treat malignancies.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

4 Patents

#162 in South San Francisco, CA

#13,678 in California

#59,049 in US

South San Francisco, CA, United States of America

Amphivena Therapeutics, Inc.